Biopharma
This content is intended for Republic of Ireland Healthcare Professionals only. For Northern Ireland, please visit the Fresenius Kabi UK website here
Idacio®⯆ (adalimumab), Tyenne®⯆(tocilizumab) and Otulfi ®⯆ prescribing information is available on the download links below. Adverse event reporting details are available at the bottom of this webpage.
- Filename
- Idacio® Prescribing Information.pdf
- Size
- 1 MB
- Format
- Filename
- Tyenne Prescribing Information.pdf
- Size
- 2 MB
- Format
- Filename
- Otulfi® Prescribing Information.pdf
- Size
- 157 KB
- Format
Adverse events should be reported.
Reporting forms and information can be found at:
www.hpra.ie/homepage/about-us/report-an-issue
Adverse events should also be reported to Fresenius Kabi Limited, Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT Tel +44 (0)1928 533 533.
Job code: IE-IDA-2500003
Date of preparation: April 2025